Contineum Therapeutics Statistics

Total Valuation

CTNM has a market cap or net worth of $182.91 million. The enterprise value is -$15.59 million.

Market Cap	182.91M
Enterprise Value	-15.59M

Important Dates

The last earnings date was Thursday, March 6, 2025, after market close.

Earnings Date	Mar 6, 2025
Ex-Dividend Date	n/a

Share Statistics

CTNM has 25.87 million shares outstanding. The number of shares has increased by 469.95% in one year.

Current Share Class	19.14M
Shares Outstanding	25.87M
Shares Change (YoY)	+469.95%
Shares Change (QoQ)	+0.33%
Owned by Insiders (%)	1.51%
Owned by Institutions (%)	40.01%
Float	13.30M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.92
P/TBV Ratio	0.92
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 20.69, with a Debt / Equity ratio of 0.03.

Current Ratio	20.69
Quick Ratio	20.53
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -26.19% and return on invested capital (ROIC) is -19.30%.

Return on Equity (ROE)	-26.19%
Return on Assets (ROA)	-18.53%
Return on Invested Capital (ROIC)	-19.30%
Return on Capital Employed (ROCE)	-25.09%
Revenue Per Employee	n/a
Profits Per Employee	-$1.03M
Employee Count	41
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	8.32
200-Day Moving Average	15.07
Relative Strength Index (RSI)	43.15
Average Volume (20 Days)	54,320

Short Selling Information

The latest short interest is 848,409, so 3.28% of the outstanding shares have been sold short.

Short Interest	848,409
Short Previous Month	869,387
Short % of Shares Out	3.28%
Short % of Float	6.38%
Short Ratio (days to cover)	15.43

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-50.89M
Pretax Income	n/a
Net Income	-42.26M
EBITDA	-50.64M
EBIT	-50.89M
Earnings Per Share (EPS)	-$2.18

Full Income Statement

Balance Sheet

The company has $204.76 million in cash and $6.26 million in debt, giving a net cash position of $198.50 million or $7.67 per share.

Cash & Cash Equivalents	204.76M
Total Debt	6.26M
Net Cash	198.50M
Net Cash Per Share	$7.67
Equity (Book Value)	198.07M
Book Value Per Share	7.66
Working Capital	196.41M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$32.85 million and capital expenditures -$514,000, giving a free cash flow of -$33.36 million.

Operating Cash Flow	-32.85M
Capital Expenditures	-514,000
Free Cash Flow	-33.36M
FCF Per Share	-$1.29

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CTNM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-469.95%
Shareholder Yield	-469.95%
Earnings Yield	-23.10%
FCF Yield	-18.24%

Analyst Forecast

The average price target for CTNM is $24.80, which is 250.78% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$24.80
Price Target Difference	250.78%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1